Reuters: India's Ranbaxy falls nearly 7 percent after Lipitor deal

[chris]

India's Ranbaxy falls nearly 7 percent after Lipitor deal
      

NEW DELHI (Reuters) - Shares in Indian drugmaker Ranbaxy Laboratories Ltd  fell nearly 7 percent on Thursday morning, after a patent dispute settlement with Pfizer Inc  was seen as offering no near-term benefit.
<p>You are not allowed to view links. Register or Login</p><div class="feedflare">
You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login
</div><img src="You are not allowed to view links. Register or Login" height="1" width="1"/>
      

You are not allowed to view links. Register or Login